Increased levels of hexacosanoic acid in the brain of Wistar rats: a behavioral study

Detalhes bibliográficos
Autor(a) principal: Marchetti, Desiree
Data de Publicação: 2021
Outros Autores: Coelho, Daniella de M, Coitinho, Adriana S, Guzzo, Edson F M, Padilha, Rafael B, Rosa, Gabriel de L, Vargas, Carmen R
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Clinical and Biomedical Research
Texto Completo: https://seer.ufrgs.br/index.php/hcpa/article/view/103339
Resumo: Introduction: X-linked adrenoleukodystrophy (X-ALD) is a peroxisomal metabolic disorder associated with mutations in the ATP-binding cassette sub-family D member1 (ABCD1) gene. Practically all male patients with X-ALD develop adrenocortical insufficiency during childhood and progressive myelopathy and peripheral neuropathy in adulthood. However, some male patients develop a fatal cerebral demyelinating disease named cerebral adrenoleukodystrophy. Although the exact mechanisms underlying brain damage in X-ALD are still poorly elucidated, it is known that hexacosanoic acid (C26:0) accumulation represents a hallmark in the pathogenesis of this disease. In this study, we examined whether an overload of C26:0 injected in Wistar rats was capable of causing behavioral changes in these animals.Methods: Egg lecithin in ethanol was dried under a nitrogen stream and mixed with C26:0 methyl ester. Male Wistar rats at 2–3 weeks of age were obtained from Universidade Federal do Rio Grande do Sul (UFRGS), divided into 8 groups, and submitted to an open field test. We then analyzed line crossings (locomotion and exploration), rearing (orienting and investigatory responses), grooming (anxiety manifestation), and latency to move for each animal.Results: Animals subjected to C26:0 administration presented fewer crossings and rearing episodes and a higher latency to move 45 minutes after C26:0 injection. The present work yields experimental evidence that C26:0, the main accumulated metabolite in X-ALD, can cause behavioral alterations in rats such as the impairment of locomotion and exploratory capabilities, as well as a reduction in orienting and investigatory responses.Conclusion: Although our results are preliminary, they are extremely important for future studies that investigate C26:0 accumulation and locomotor impairment in patients with X-ALD.
id UFRGS-20_883a4ff138a7e80552e8020d2d3dd9c9
oai_identifier_str oai:seer.ufrgs.br:article/103339
network_acronym_str UFRGS-20
network_name_str Clinical and Biomedical Research
repository_id_str
spelling Increased levels of hexacosanoic acid in the brain of Wistar rats: a behavioral studyX-linked adrenoleukodystrophyC26Wistar ratsopen field.Introduction: X-linked adrenoleukodystrophy (X-ALD) is a peroxisomal metabolic disorder associated with mutations in the ATP-binding cassette sub-family D member1 (ABCD1) gene. Practically all male patients with X-ALD develop adrenocortical insufficiency during childhood and progressive myelopathy and peripheral neuropathy in adulthood. However, some male patients develop a fatal cerebral demyelinating disease named cerebral adrenoleukodystrophy. Although the exact mechanisms underlying brain damage in X-ALD are still poorly elucidated, it is known that hexacosanoic acid (C26:0) accumulation represents a hallmark in the pathogenesis of this disease. In this study, we examined whether an overload of C26:0 injected in Wistar rats was capable of causing behavioral changes in these animals.Methods: Egg lecithin in ethanol was dried under a nitrogen stream and mixed with C26:0 methyl ester. Male Wistar rats at 2–3 weeks of age were obtained from Universidade Federal do Rio Grande do Sul (UFRGS), divided into 8 groups, and submitted to an open field test. We then analyzed line crossings (locomotion and exploration), rearing (orienting and investigatory responses), grooming (anxiety manifestation), and latency to move for each animal.Results: Animals subjected to C26:0 administration presented fewer crossings and rearing episodes and a higher latency to move 45 minutes after C26:0 injection. The present work yields experimental evidence that C26:0, the main accumulated metabolite in X-ALD, can cause behavioral alterations in rats such as the impairment of locomotion and exploratory capabilities, as well as a reduction in orienting and investigatory responses.Conclusion: Although our results are preliminary, they are extremely important for future studies that investigate C26:0 accumulation and locomotor impairment in patients with X-ALD.HCPA/FAMED/UFRGS2021-03-11info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionPeer-reviewed ArticleAvaliado por Paresapplication/pdfhttps://seer.ufrgs.br/index.php/hcpa/article/view/103339Clinical & Biomedical Research; Vol. 40 No. 3 (2020): Clinical and Biomedical ResearchClinical and Biomedical Research; v. 40 n. 3 (2020): Clinical and Biomedical Research2357-9730reponame:Clinical and Biomedical Researchinstname:Universidade Federal do Rio Grande do Sul (UFRGS)instacron:UFRGSenghttps://seer.ufrgs.br/index.php/hcpa/article/view/103339/pdfCopyright (c) 2021 Clinical and Biomedical Researchinfo:eu-repo/semantics/openAccessMarchetti, DesireeCoelho, Daniella de MCoitinho, Adriana SGuzzo, Edson F MPadilha, Rafael BRosa, Gabriel de LVargas, Carmen R2024-01-19T14:21:04Zoai:seer.ufrgs.br:article/103339Revistahttps://www.seer.ufrgs.br/index.php/hcpaPUBhttps://seer.ufrgs.br/index.php/hcpa/oai||cbr@hcpa.edu.br2357-97302357-9730opendoar:2024-01-19T14:21:04Clinical and Biomedical Research - Universidade Federal do Rio Grande do Sul (UFRGS)false
dc.title.none.fl_str_mv Increased levels of hexacosanoic acid in the brain of Wistar rats: a behavioral study
title Increased levels of hexacosanoic acid in the brain of Wistar rats: a behavioral study
spellingShingle Increased levels of hexacosanoic acid in the brain of Wistar rats: a behavioral study
Marchetti, Desiree
X-linked adrenoleukodystrophy
C26
Wistar rats
open field.
title_short Increased levels of hexacosanoic acid in the brain of Wistar rats: a behavioral study
title_full Increased levels of hexacosanoic acid in the brain of Wistar rats: a behavioral study
title_fullStr Increased levels of hexacosanoic acid in the brain of Wistar rats: a behavioral study
title_full_unstemmed Increased levels of hexacosanoic acid in the brain of Wistar rats: a behavioral study
title_sort Increased levels of hexacosanoic acid in the brain of Wistar rats: a behavioral study
author Marchetti, Desiree
author_facet Marchetti, Desiree
Coelho, Daniella de M
Coitinho, Adriana S
Guzzo, Edson F M
Padilha, Rafael B
Rosa, Gabriel de L
Vargas, Carmen R
author_role author
author2 Coelho, Daniella de M
Coitinho, Adriana S
Guzzo, Edson F M
Padilha, Rafael B
Rosa, Gabriel de L
Vargas, Carmen R
author2_role author
author
author
author
author
author
dc.contributor.author.fl_str_mv Marchetti, Desiree
Coelho, Daniella de M
Coitinho, Adriana S
Guzzo, Edson F M
Padilha, Rafael B
Rosa, Gabriel de L
Vargas, Carmen R
dc.subject.por.fl_str_mv X-linked adrenoleukodystrophy
C26
Wistar rats
open field.
topic X-linked adrenoleukodystrophy
C26
Wistar rats
open field.
description Introduction: X-linked adrenoleukodystrophy (X-ALD) is a peroxisomal metabolic disorder associated with mutations in the ATP-binding cassette sub-family D member1 (ABCD1) gene. Practically all male patients with X-ALD develop adrenocortical insufficiency during childhood and progressive myelopathy and peripheral neuropathy in adulthood. However, some male patients develop a fatal cerebral demyelinating disease named cerebral adrenoleukodystrophy. Although the exact mechanisms underlying brain damage in X-ALD are still poorly elucidated, it is known that hexacosanoic acid (C26:0) accumulation represents a hallmark in the pathogenesis of this disease. In this study, we examined whether an overload of C26:0 injected in Wistar rats was capable of causing behavioral changes in these animals.Methods: Egg lecithin in ethanol was dried under a nitrogen stream and mixed with C26:0 methyl ester. Male Wistar rats at 2–3 weeks of age were obtained from Universidade Federal do Rio Grande do Sul (UFRGS), divided into 8 groups, and submitted to an open field test. We then analyzed line crossings (locomotion and exploration), rearing (orienting and investigatory responses), grooming (anxiety manifestation), and latency to move for each animal.Results: Animals subjected to C26:0 administration presented fewer crossings and rearing episodes and a higher latency to move 45 minutes after C26:0 injection. The present work yields experimental evidence that C26:0, the main accumulated metabolite in X-ALD, can cause behavioral alterations in rats such as the impairment of locomotion and exploratory capabilities, as well as a reduction in orienting and investigatory responses.Conclusion: Although our results are preliminary, they are extremely important for future studies that investigate C26:0 accumulation and locomotor impairment in patients with X-ALD.
publishDate 2021
dc.date.none.fl_str_mv 2021-03-11
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
Peer-reviewed Article
Avaliado por Pares
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://seer.ufrgs.br/index.php/hcpa/article/view/103339
url https://seer.ufrgs.br/index.php/hcpa/article/view/103339
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://seer.ufrgs.br/index.php/hcpa/article/view/103339/pdf
dc.rights.driver.fl_str_mv Copyright (c) 2021 Clinical and Biomedical Research
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2021 Clinical and Biomedical Research
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv HCPA/FAMED/UFRGS
publisher.none.fl_str_mv HCPA/FAMED/UFRGS
dc.source.none.fl_str_mv Clinical & Biomedical Research; Vol. 40 No. 3 (2020): Clinical and Biomedical Research
Clinical and Biomedical Research; v. 40 n. 3 (2020): Clinical and Biomedical Research
2357-9730
reponame:Clinical and Biomedical Research
instname:Universidade Federal do Rio Grande do Sul (UFRGS)
instacron:UFRGS
instname_str Universidade Federal do Rio Grande do Sul (UFRGS)
instacron_str UFRGS
institution UFRGS
reponame_str Clinical and Biomedical Research
collection Clinical and Biomedical Research
repository.name.fl_str_mv Clinical and Biomedical Research - Universidade Federal do Rio Grande do Sul (UFRGS)
repository.mail.fl_str_mv ||cbr@hcpa.edu.br
_version_ 1799767055710289920